The key therapeutic topic lipid-modifying drugs has been retired from the 2018 update of medicines optimisation: key therapeutic topics. The version published in 2017 is available here for information but it has not been updated since January 2017. Like all the other key therapeutic topics it is not formal NICE guidance.